Cargando…

Exploring the Mechanism of Hawthorn Leaves Against Coronary Heart Disease Using Network Pharmacology and Molecular Docking

Hawthorn leaves, which is a traditional Chinese medicine (TCM), has been used for treating coronary heart disease (CHD) for a long time in China. But the limited understanding of the main active components and molecular mechanisms of this traditional medicine has restricted its application and furth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ding, Jie, Wu, Jun, Wei, Haoran, Li, Sui, Huang, Man, Wang, Yan, Fang, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243333/ https://www.ncbi.nlm.nih.gov/pubmed/35783840 http://dx.doi.org/10.3389/fcvm.2022.804801

Ejemplares similares

Potential Mechanism of Dingji Fumai Decoction Against Atrial Fibrillation Based on Network Pharmacology, Molecular Docking, and Experimental Verification Integration Strategy
por: Liang, Yi, et al.
Publicado: (2021)

Network pharmacology and molecular docking-based analysis of protective mechanism of MLIF in ischemic stroke
por: Lv, Mengting, et al.
Publicado: (2022)

Editorial: Non-coding RNA and Coronary Heart Disease
por: He, Shu, et al.
Publicado: (2022)

β-sheets in serum protein are independent risk factors for coronary lesions besides LDL-C in coronary heart disease patients
por: Li, Yu-lin, et al.
Publicado: (2022)

Incident Heart Failure in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
por: Gu, Jun, et al.
Publicado: (2021)

The impact of valvular heart disease in patients with chronic coronary syndrome
por: Molenaar, Mitchel A., et al.
Publicado: (2023)

Comparative efficacy and pharmacological mechanism of Chinese patent medicines against anthracycline-induced cardiotoxicity: An integrated study of network meta-analysis and network pharmacology approach
por: Rao, Yifei, et al.
Publicado: (2023)

Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications
por: Meyer, Albertus A., et al.
Publicado: (2022)

Role of sex on the efficacy of pharmacological and non-pharmacological treatment of heart failure with reduced ejection fraction: A systematic review
por: Sanromán Guerrero, María Ascensión, et al.
Publicado: (2022)

Functional Deletion/Insertion Promoter Variants in SCARB1 Associated With Increased Susceptibility to Lipid Profile Abnormalities and Coronary Heart Disease
por: Hu, Senlin, et al.
Publicado: (2022)

Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve
por: Yong, Jingwen, et al.
Publicado: (2020)

Association Between Social Support and Medication Literacy in Chinese Patients With Coronary Heart Disease
por: Qiao, Li, et al.
Publicado: (2021)

The Role of the VEGF Family in Coronary Heart Disease
por: Zhou, Yan, et al.
Publicado: (2021)

Coronary microvascular dysfunction in heart failure patients
por: Toya, Takumi, et al.
Publicado: (2023)

Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets
por: Correale, Michele, et al.
Publicado: (2023)

Exploring the Therapeutic Mechanisms of Huzhang–Shanzha Herb Pair against Coronary Heart Disease by Network Pharmacology and Molecular Docking
por: Li, Dan, et al.
Publicado: (2021)

Knockdown of lncRNA ENST00000609755.1 Confers Protection Against Early oxLDL-Induced Coronary Heart Disease
por: Sun, Yi, et al.
Publicado: (2021)

Effect of social app-assisted education and support on glucose control in patients with coronary heart disease and diabetes mellitus
por: Zhong, Jing, et al.
Publicado: (2022)

Exploration of Mechanisms of Sacubitril/Valsartan in the Treatment of Cardiac Arrhythmias Using a Network Pharmacology Approach
por: Zhou, Yu, et al.
Publicado: (2022)

Exploring the Mechanism of Danshensu in the Treatment of Doxorubicin-Induced Cardiotoxicity Based on Network Pharmacology and Experimental Evaluation
por: Qi, Jia-ying, et al.
Publicado: (2022)

Incremental value of non-invasive myocardial work for the evaluation and prediction of coronary microvascular dysfunction in angina with no obstructive coronary artery disease
por: Li, Ying, et al.
Publicado: (2023)

Hawthorn leaves flavonoids attenuate cardiac remodeling induced by simulated microgravity
por: Liu, Tian, et al.
Publicado: (2023)

Exploring Coronary Artery Disease GWAs Targets With Functional Links to Immunometabolism
por: Hughes, Maria F., et al.
Publicado: (2018)

Development and Validation of a Prognostic Model to Predict High-Risk Patients for Coronary Heart Disease in Snorers With Uncontrolled Hypertension
por: Wang, Meng-hui, et al.
Publicado: (2022)

Characteristics of Blood Metabolic Profile in Coronary Heart Disease, Dilated Cardiomyopathy and Valvular Heart Disease Induced Heart Failure
por: Liu, Chang, et al.
Publicado: (2021)

Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease
por: Zhang, Yingyue, et al.
Publicado: (2021)

The portable Hawthorne /
por: Hawthorne, Nathaniel, 1804-1864
Publicado: (1948)

Nathaniel Hawthorne/
por: Martin, Terence 1946-

Socioeconomic inequalities in coronary heart disease risk in older age: contribution of established and novel coronary risk factors
por: RAMSAY, S E, et al.
Publicado: (2009)

Prediction of myocardial ischemia in coronary heart disease patients using a CCTA–Based radiomic nomogram
por: Yang, You-Chang, et al.
Publicado: (2023)

Prognostic value of remnant cholesterol in patients with coronary heart disease: A systematic review and meta-analysis of cohort studies
por: Tian, Yun, et al.
Publicado: (2023)

Risk factors and coronary artery outcomes of coronary artery aneurysms differing in size and emergence time in children with Kawasaki disease
por: Liu, Jie, et al.
Publicado: (2022)

Commentary: Heart Fat Infiltration in Subjects With and Without Coronary Artery Disease
por: Chirumbolo, Salvatore
Publicado: (2016)

circRNA, a novel diagnostic biomarker for coronary heart disease
por: Tong, Xiao, et al.
Publicado: (2023)

Editorial: Inflammatory factors in coronary heart disease: mechanism, diagnosis, and therapy
por: Dong, Qian, et al.
Publicado: (2023)

Epicardial Contribution to the Developing and Injured Heart: Exploring the Cellular Composition of the Epicardium
por: Streef, Thomas J., et al.
Publicado: (2021)

Establishment and Validation of a Non-invasive Diagnostic Nomogram to Identify Heart Failure in Patients With Coronary Heart Disease
por: Tan, Juntao, et al.
Publicado: (2022)

Correlation Between Smoking Paradox and Heart Rhythm Outcomes in Patients With Coronary Artery Disease Receiving Percutaneous Coronary Intervention
por: Wu, Han-Ping, et al.
Publicado: (2022)

Defining and evaluating the Hawthorne effect in primary care, a systematic review and meta-analysis
por: Berkhout, Christophe, et al.
Publicado: (2022)

The Potential Bioactive Components of Nine TCM Prescriptions Against COVID-19 in Lung Cancer Were Explored Based on Network Pharmacology and Molecular Docking
por: Du, Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5hs7l2h0qnic74fek9mi9387h2